OV monitor (CA 125 Antigen)
Navigation Links
OV monitor (CA 125 Antigen)
| Products | OV monitor (CA 125 Antigen) |
| Company | Beckman Coulter, Inc. |
| Item | OV monitor (CA 125 Antigen) |
| Features | Access OV Monitor aids in the management of ovarian cancer and is designed for the quantitative determination of cancer antigen 125 (CA 125) levels in human serum and plasma. CA 125 antigen levels are most consistently elevated in patients with ovarian cancer. |
| Description | Ovarian Cancer Test |
| Info | Beckman Coulter, Inc. Customer Service: (800) 742-2345 Web site: http://www.beckmancoulter.com |
Related medicine products :
1. TCM40 tcpO2/tcpCO2 monitor
2. TCM400 multi-channel tcpO2 monitor
3. TOSCA 500 SpO2/tcpCO2 monitor
4. MicroGas 7650 rapid tcpCO2/tcpO2 monitor
5. Discmonitor Discography System
6. TeleMon companion monitor
7. PSA Screen (Prostate Specific Antigen)
Breaking Medicine News(10 mins):Health News:Prostate Hormone Therapy May Up Heart Risks 2Health News:Prostate Hormone Therapy May Up Heart Risks 3Health News:Pitt study suggests craving hinders comprehension without you realizing it 2Health News:EPA: Greenhouse Gases Hazardous to Your Health 2Health News:EPA: Greenhouse Gases Hazardous to Your Health 3Health News:Oncologist at the Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization 2Health News:Oncologist at the Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization 3Health News:Oncologist at the Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization 4Health News:Hospice Foundation of America Presents Webinar on 'Bereavement Camps for Kids: Benefits and Challenges' 2
[0] Prostate Hormone Therapy May Up Heart Risks[0] Pitt study suggests craving hinders comprehension without you realizing it[0] EPA: Greenhouse Gases Hazardous to Your Health [1] Oncologist at the Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization[0] Hospice Foundation of America Presents Webinar on 'Bereavement Camps for Kids: Benefits and Challenges'
Other Medicine News:Health News:Shortage of Doctors and Nurses Affects AIDS Treatment in Africa 2Health News:Shortage of Doctors and Nurses Affects AIDS Treatment in Africa 3Health News:New Mouse Model to Aid in Cancer-causing Genes Hunt 2Health News:Researchers Discover Starch Cocktail Fuel for green Car 2
Shortage of Doctors and Nurses Affects AIDS Treatment in AfricaNew Mouse Model to Aid in Cancer-causing Genes HuntResearchers Discover Starch Cocktail Fuel for green CarResearchers Make Insulin from Human Umbilical Cord Bloods Adult Stem CellsReferring Dental Patients to Telephone quitlines may Help Them Stop SmokingAnthrax Claims Two Lives in Orissa
Breaking Medicine Technology:Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3New AMA Ad Emphasizes Common Ground on Health Reform Shares Vision to Fix Broken System 52955 1New AMA Ad Emphasizes Common Ground on Health Reform Shares Vision to Fix Broken System 52955 2HOWARU 28R 29 Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 52951 1HOWARU 28R 29 Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 52951 2
[0] Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting[0] HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million[0] TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |